Product
Peripheral Intravenous (IV) infusion of LMSCs
1 clinical trial
2 indications
Indication
Metabolic disorderIndication
Endothelial dysfunctionClinical trial
A Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Efficacy of Allogeneic Human Mesenchymal Stem Cells in Patients With Metabolic Syndrome.Status: Withdrawn, Estimated PCD: 2023-12-01